Hilton Stock Is Jumping Post Q1 Results – Here’s Why

Hilton Worldwide surpasses analyst estimates with first-quarter FY24 sales reaching $2.573 billion, marking a 12.2% year-on-year increase. Franchise and licensing fees revenue rose 12.4%, while the company's owned and leased hotels revenue grew by 2.8%.

Hilton Worldwide Holdings Inc (NYSE:HLT) reported first-quarter FY24 sales growth of 12.2% year-on-year to $2.573 billion, beating the analyst consensus estimate of $2.550 billion.

Franchise and licensing fees revenue rose 12.4% Y/Y, and the owned and leased hotels revenue grew 2.8%.

The occupancy rate for the quarter was 67.7% in the U.S., 64.9% in Europe and 73.6% in Middle East & Africa. In total, the system-wide occupancy rate was 67.2%.

On a currency-neutral basis, System-wide comparable RevPAR increased 2% Y/Y. In the first quarter, Hilton added 16,800 rooms to its system.

The operating margin was 20.7%, and operating income for the quarter increased 7% to $533 million.

Adjusted EBITDA of $750 million increased 17% Y/Y. Adjusted EBITDA margin expanded 260 basis points to 70.4%.

Adjusted EPS of $1.53 beat the analyst consensus of $1.42.

Outlook: Hilton raised its FY24 adjusted EPS outlook from $6.80 – $6.94 to $6.89-$7.03 versus the Street view of $7.12.

Hilton expects system-wide comparable RevPAR on a currency neutral basis to increase 2%-4% for FY24. The company expects an FY24 capital return of approximately $3.0 billion.

HLT sees second quarter adjusted EPS of $1.80-$1.86 versus an estimate of $1.88; system-wide comparable RevPAR growth on a currency neutral basis of 2%-4%.

HLT Price Action: HLT shares are trading higher by 4.41% at $205.74 premarket Wednesday.

Photo via Wikimedia Commons

Total
0
Shares
Related Posts
Read More

Verona Pharma’s Promising COPD Treatment Puts It in GSK’s Acquisition Crosshairs, Analysts Predict Big Moves

In recent statements to the Financial Times and The Sunday Times, GSK plc (NYSE: GSK) Chief Commercial Officer Luke Miels revealed the company's intent to pursue acquisitions within the $2 billion (£1.6 billion) range over the upcoming six months, aiming to fortify its pipeline.

GSK

Read More

Earnings Preview: CoStar Group

CoStar Group (NASDAQ:CSGP) is set to give its latest quarterly earnings report on Tuesday, 2022-07-26. Here's what investors need to know before the announcement. Analysts estimate that CoStar Group will report an earnings per share (EPS) of $0.21.

CSGP